tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Convatec CEO Sells Minority Shareholding Amid Medical Leave

Story Highlights
Convatec CEO Sells Minority Shareholding Amid Medical Leave

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

ConvaTec ( (GB:CTEC) ) has provided an update.

Convatec announced that its CEO, Karim Bitar, sold a minority portion of his shares in the company for personal reasons unrelated to the business. Despite this sale, Bitar retains a significant stake in Convatec and expressed confidence in the company’s strong leadership and growth prospects. This transaction, disclosed under the Market Abuse Regulation, is not expected to impact the company’s operations or strategic direction.

The most recent analyst rating on (GB:CTEC) stock is a Buy with a £305.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.

Spark’s Take on GB:CTEC Stock

According to Spark, TipRanks’ AI Analyst, GB:CTEC is a Neutral.

ConvaTec’s strong financial performance and strategic positioning are tempered by bearish technical indicators and a high valuation. Regulatory challenges may pose risks, but the company’s innovation pipeline and operational strength support a moderately positive outlook.

To see Spark’s full report on GB:CTEC stock, click here.

More about ConvaTec

Convatec is a global medical products and technologies company focused on solutions for managing chronic conditions. It holds leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care, providing products and services in around 90 countries. The company is part of the FTSE 100 Index and reported revenues of over $2 billion in 2024.

Average Trading Volume: 7,343,181

Technical Sentiment Signal: Sell

Current Market Cap: £4.69B

See more insights into CTEC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1